Welcome!
ALERT Upcoming Training Opportunities:
Do you need help finding specialized equipment or expert services for your research? Whether you are new to the Pitt research community or a regular shared facility user, join one of our upcoming webinars to learn more about the resources available across campus. These sessions will offer an overview of resources available, how to access equipment and services, iLab training, and an opportunity to ask questions.
Join one of the following two webinars:
No prior registration is required and anyone is welcome to join.
In addition, save the date for an in-person Shared Facility Showcase on the afternoon of Monday, October 19, 2026. More information about this event and how to register will be shared soon.
(hide this warning on this page)
Mission: Deliver high-quality and safe translation of cutting-edge scientific breakthroughs into CGT therapies for improving human health.
The Immunologic Monitoring and Cellular Products Laboratory (IMCPL) is a FACT-accredited, FDA-registered GMP core facility supporting cell and gene therapy (CGT) research from early development through clinical translation. With 9 GMP clean rooms at the Riviera building in the Pittsburgh Technology Center, IMCPL partners with investigators on Phase 1–3 clinical programs for cancer, autoimmune, and rare diseases, while also providing immunologic monitoring services for clinical trials. IMCPL functions as an industry-style development partner, offering end‑to‑end expertise in CGT product development and clinical manufacturing. Services include process development and scale‑up, GMP manufacturing, quality assurance and quality control, and generation of Chemistry, Manufacturing, and Controls (CMC) documentation for IND submissions. Manufacturing capabilities include CAR‑T, TCR‑engineered cells, dendritic cell vaccines, gamma delta T cells, tumor‑infiltrating lymphocytes, and gene therapy, with integrated QC testing for identity, potency, safety, stability, and immunomonitoring. IMCPL supports investigators from proof‑of‑concept through delivery of clinical‑ready therapies.
For more information about cell and gene therapy, ongoing clinical research and additional resources, visit the IMCPL website or email IMCPL@pitt.edu for consultations.
Primary Sq. Ft: 9203
|
Days of the Week |
Hours open |
|
Monday – Friday |
8:30 am – 5:00 pm |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Devanjan Sikder, DVM, MS, PhD |
Director
|
des367@pitt.edu
|
350 Technology Drive
|
|
| Brigitte Senechal, PharmD, CP, PhD |
Associate Director, Quality and Operations
|
brs511@pitt.edu
|
350 Technology Drive
|
|
| Veronica Sutherland |
Assistant Director, Manufacturing
|
ves83@pitt.edu
|
350 Technology Drive
|
|
| Sunita Shinde, MS |
Facility Manager
|
sns202@pitt.edu
|
350 Technology Drive
|
|
| IMCPL |
General Email
|
IMCPL@pitt.edu
|
350 Technology Drive
|
|
| Tracy Crawford |
Administrative Assistant Director (Billing Questions Only)
|
412-648-9440
|
tlc@pitt.edu
|
3500 Fifth Avenue Suite 202
|
| Amy Lyn Elliott |
Finance Administrator (Billing Questions Only)
|
412-648-9440
|
alh54@pitt.edu
|
3500 Fifth Avenue Suite 202
|
| Erin Lasswell |
Administrative Coordinator (Billing Questions Only)
|
412-648-9440
|
ecl41@pitt.edu
|
3500 Fifth Avenue Suite 202
|
| Jason Sun |
Information Technology Manager
|
412-648-9440
|
jis30@pitt.edu
|
3500 Fifth Avenue Suite 202
|
